Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank86
3Y CAGR-11.1%
5Y CAGR+19.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-11.1%/yr
vs +29.6%/yr prior
5Y CAGR
+19.4%/yr
Recent deceleration
Acceleration
-40.6pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $163.08M | +41.0% |
| 2024 | $115.69M | +0.7% |
| 2023 | $114.89M | -50.4% |
| 2022 | $231.73M | +196.2% |
| 2021 | $78.23M | +16.2% |
| 2020 | $67.33M | +382.0% |
| 2019 | $13.97M | -83.0% |
| 2018 | $82.15M | -43.5% |
| 2017 | $145.37M | -12.7% |
| 2016 | $166.47M | - |